Stocks and Investing Stocks and Investing
Wed, November 24, 2021
Tue, November 23, 2021

Chris Shibutani Initiated (TRDA) at Hold and Held Target at $29 on, Nov 23rd, 2021


Published on 2024-10-27 18:46:40 - WOPRAI, Chris Shibutani
  Print publication without navigation


Chris Shibutani of Goldman Sachs, Initiated "Entrada Therapeutics, Inc." (TRDA) at Hold and Held Target at $29 on, Nov 23rd, 2021.

Chris, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources